particles insight to promote
Plaxgen CLIA lab offers
clinical diagnosis tests for
Plaque Array technology combining
Flow cytometry & Mass spectrometry
for the identification of
biomarkers in blood
Plaque load tests
detecting Lipoprotein particles
Statin Response and
Abeta particles in blood
Founded in 2007, Plaxgen is a biodiagnostics company with a unique diagnostic platform to personalized medicine. We are focused on developing innovative technology for clinical diagnostics and the discovery of effective therapeutics to treat a broad spectrum of plaque-related diseases, including Alzheimer’s disease (AD) and atherosclerosis. Plaxgen’s proprietary Plaque Array platform was developed to detect and characterize serum-derived particles containing cholesterol or amyloid beta protein (abeta), tau and α-synuclein. These plaque particles play key roles in the formation and progression …
Plaxgen Inc is a licensed and CLIA certified lab offers the ATHEROLoad™, StatRes™ and AMYLoad™ tests.
Detecting and quantifying serum-derived plaque particles for diagnosis and drug discovery.
Improved and personalized non-invasive diagnostic assays for cardiovascular and Alzheimer’s diseases.
© COPYRIGHT 2014 PLAXGEN.COM, ALL RIGHTS RESERVED.